Encompass Health Corporation (NYSE:EHC) Shares Purchased by TimesSquare Capital Management LLC

TimesSquare Capital Management LLC increased its position in Encompass Health Corporation (NYSE:EHC - Free Report) by 5.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 397,641 shares of the company's stock after buying an additional 22,090 shares during the period. TimesSquare Capital Management LLC owned about 0.39% of Encompass Health worth $40,273,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Colonial Trust Co SC acquired a new position in shares of Encompass Health during the 4th quarter valued at about $29,000. Transce3nd LLC purchased a new stake in Encompass Health in the fourth quarter valued at approximately $40,000. CBIZ Investment Advisory Services LLC increased its position in Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after purchasing an additional 127 shares during the last quarter. Arlington Trust Co LLC raised its stake in Encompass Health by 22.9% during the first quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock worth $68,000 after purchasing an additional 125 shares during the period. Finally, Signaturefd LLC grew its stake in shares of Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after buying an additional 125 shares during the period. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Stock Up 0.3%

NYSE EHC traded up $0.36 during trading hours on Thursday, reaching $110.28. 1,155,220 shares of the company traded hands, compared to its average volume of 731,885. The company has a 50 day moving average of $119.18 and a two-hundred day moving average of $106.70. The stock has a market capitalization of $11.12 billion, a PE ratio of 22.78, a PEG ratio of 2.23 and a beta of 0.88. Encompass Health Corporation has a 12 month low of $82.74 and a 12 month high of $123.13. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.81.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The firm had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same period in the previous year, the company earned $1.12 earnings per share. Encompass Health's quarterly revenue was up 10.6% on a year-over-year basis. As a group, equities analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st were paid a dividend of $0.17 per share. The ex-dividend date of this dividend was Tuesday, July 1st. This represents a $0.68 annualized dividend and a yield of 0.62%. Encompass Health's payout ratio is 14.05%.

Analyst Ratings Changes

Several research analysts recently weighed in on EHC shares. UBS Group increased their target price on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Truist Financial reiterated a "buy" rating and issued a $135.00 target price (up previously from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research report on Thursday, June 5th. Barclays upped their price target on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a report on Friday, April 25th. Finally, KeyCorp lifted their price objective on shares of Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a research note on Tuesday, May 27th. Seven investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Encompass Health presently has an average rating of "Buy" and an average target price of $131.50.

Insiders Place Their Bets

In related news, EVP John Patrick Darby sold 10,000 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the transaction, the executive vice president owned 79,710 shares in the company, valued at $9,149,910.90. The trade was a 11.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Mark J. Tarr sold 118,384 shares of the business's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the transaction, the chief executive officer directly owned 527,070 shares of the company's stock, valued at approximately $64,054,817.10. This trade represents a 18.34% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 132,663 shares of company stock valued at $16,034,082. Company insiders own 2.00% of the company's stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.